Texas Attorney General Ken Paxton has sued Eli Lilly, alleging the drugmaker offered illegal incentives to providers, leading ...

Texas Attorney General Ken Pax­ton said on Tuesday that he has sued pharmaceutical giant Eli Lilly and Co. (LLY) for "bribing ...

Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical giant Eli Lilly, accusing the company of bribing medical providers to prescribe its lucrative medications. The lawsuit ...

Texas AG sues Eli Lilly for bribery related to prescribing GLP-1 meds for weight loss and diabetes, alleging unethical inducements to medical providers.

Patients taking the GLP-1 weight loss drug Zepbound face mandatory switch to Wegovy after CVS Caremark removed the Eli Lilly medication from its preferred coverage list, citing rising costs.

Popular weight-loss and diabetes drugs, including Ozempic and Zepbound, may be connected to rare eye conditions that could lead to vision loss, according to a new study published in JAMA ...

The Patients Forced to Switch From Zepbound to Wegovy Some shift to save money in response to CVS Caremark restrictions; others appeal for Zepbound coverage, citing better weight-loss results By ...

About Zepbound® (tirzepatide) injection Zepbound ® (tirzepatide) injection is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity.

A best practice is to rotate injection sites each week. Do not inject Zepbound into tender, bruised, scaly, or hard skin or into scars or damaged skin.